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Abstract 
Nuclear medicine is a specialty that uses radioactive nuclei for therapy or 
diagnostic of diseases such as different types of cancer. The aim of this 
paper is to give the status of nuclear data collected for medical isotopes 
production and to present the large set of experimental data collected by the 
PRISMA team of the Subatech laboratory using the protons, deuterons and 
alpha particles delivered by the ARRONAX cyclotron from few MeV up to 
70 MeV and covering a wide range of target masses. Using these data, we 
will also show that constrains can be put on simulation tools such as the 
TALYS code (version 1.9) and compare with TENDL-2015, the TALYS-
based evaluated nuclear data library. A better overall agreement with our 
experimental data could be obtained with a different combination of models 
already included in the code. 
1 Introduction 
Our research activities are focused on radionuclide production mainly for medical applications, either 
for therapy or diagnosis. This work is carried out in close collaboration with the GIP ARRONAX that 
possesses a high energy and high intensity multi-particle cyclotron [1]. In this frame, production cross 
sections and thick target yields were measured for alpha emitters, such as the U-230/Th-226, Th-
227/Ra-223 and Ac-225/Bi-213 generators [2]; for photon, Tc-99m [2], and positon, Sc-44g [3], 
emitters for diagnosis; for electron emitters Re-186g [4], Tb-155 [5] and Sn-117m [6] for therapeutic 
applications. From the irradiated materials, new experimental production cross section data of interest 
for medical applications and monitor reactions have been extracted which allow to expand our 
knowledge on these excitation functions, to confirm the existing trends and to give additional values 
on a wider energy range. These experiments were conducted at the ARRONAX facility using the 
stacked-foil technique.  
This data set only represents a small part of the data needed in the field studying the production 
of innovative radionuclides for medical applications. In order to get answers quickly without the need 
of new experiments, it is interesting to use theoretical models. The TALYS code gather together 
several of such models for each step of a nuclear interaction. A systematic comparison of our results 
with the output of the TENDL-2015 nuclear data library and TALYS code (version 1.9) has been 
done. In this latter case, several combinations of models have been tested in order to better reproduce 
the available data. 
2 Experimental set-up and production cross section calculation 
The production cross section data are obtained using the stacked-foil method [2, 7], which consists of 
the irradiation of a set of thin foils, grouped as patterns. Each pattern contains a target to produce the 
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isotopes of interest. Each target is followed by a monitor foil to have information on the beam 
intensity thanks to the use of a reference reaction recommended by the International Atomic Energy 
Agency [8]. A degrader foil is placed after each monitor foil to change the incident beam energy from 
one target foil to the next one. Each foil in the stack is weighed before irradiation using an accurate 
scale (± 10-5 g) and scanned to precisely determine its area. The thickness is deduced from these 
values, assuming that it is homogeneous over the whole surface. In this work, we used thin target and 
monitor foils of a few tens of micrometres thick and degrader foils of few hundreds of micrometres 
thick. All foils were purchased from the Good Fellow© company. 
These foils were irradiated by proton (up to 70 MeV), deuteron (up to 34 MeV) or alpha 
particle (68 MeV) beams provided by the ARRONAX cyclotron. It delivers these beams with an 
energy uncertainty of ± 0.50 MeV, ± 0.25 MeV and ± 0.61 MeV, respectively for p, d or alpha 
particle, as specified by the cyclotron provider using simulations. The beam line is under vacuum and 
closed using a 75 µm thick kapton foil. The stacks were located about 6.8 cm downstream in air. The 
energy through each foil has been determined in the middle of the thickness of the foil using the SRIM 
software [9]. Energy losses in the kapton foil and air have been taken into account in our analysis. All 
along the stack, depending on the number of foils, the energy uncertainty increases up to ± 2.0 MeV 
due to the energy straggling. Irradiations were usually carried out for half an hour, with beams of 
mean intensity between 100 and 150 nA for proton, between 50 and 140 nA for deuteron and between 
140 and 200 nA particles for alpha beam. The recommended production cross section values [8] of the 
Ti-nat(d, x)V-48 (all energies), Cu-nat(p,x)Co-56, Zn-62 (> 50 MeV), Ti-nat(p,x)V-48 (< 20 MeV), 
Ni-nat(p,x)Ni-57 (20-50 MeV), Cu-nat(α,x)Ga-67 (up to 50 MeV) and Al-27(α,x)Na-22 (from 50 
MeV to 70 MeV) reactions were used to get information on the beam intensity, depending on the 
investigated energy range. 
The activity measurements in each foil were performed using a high purity germanium detector 
from Canberra (France) with low-background lead and copper shielding. The first measurements 
started the day after the irradiation (after a minimum of 15 hours cooling time) during one hour, for all 
target and monitor foils. Our data are then limited to γ emitter radionuclides with a half-life higher 
than few hours. A second series of measurements was performed one week after End Of Beam, during 
a minimum of 24 hours (one day) and up to 60 hours. Third measurements were devoted to long half-
life radionuclides and also waiting for the decay of some radionuclides. Gamma spectra were recorded 
in a suitable geometry calibrated in energy and efficiency with standard Co-57, Co-60 and Eu-152 
gamma sources from LEA-CERCA (France). The full widths at half maxima were 1.04 keV at 122 
keV (Co-57 γ ray) and 1.97 keV at 1332 keV (Co-60 γ ray). The samples were placed at a distance of 
19 cm from the detector, which is suited to reduce the dead time and the effect of sum peaks. The 
dead time during the counting was always kept below 10%. 
The production cross section values are calculated using the well-known activation formula, 
defined as a relative equation in which the knowledge of the beam current is no longer necessary 
thanks to the recommended reactions. The uncertainty is expressed as a propagation error calculation 
(see [6] for more details). 
3 The TALYS code and TENDL data library 
In this article, all the experimental production cross section values are compared with the version 1.9 
of the TALYS code released in December, 2017 [10]. TALYS is a nuclear reaction program which 
simulates reactions induced by light particles, neutrons, photons, protons, deuterons, tritons, 3He- and 
alpha-particles, on target nuclides of mass 12 and heavier. It incorporates theoretical models to predict 
observables including production cross section values as a function of the incident particle energy (up 
to 1 GeV). A combination of models that best describes the whole set of available data for all 
projectiles, targets and incident energies have been defined by the authors and put as default in the 
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code. In this way, a calculation can be performed with minimum information in the input file: the type 
of projectile and its incident energy, the target type and its mass. The results of this combination of 
models are referenced in Fig. 1 to 4 as TALYS 1.9 Default. 
TENDL is a TALYS-based Evaluated Nuclear Data Library using both default and adjusted 
TALYS calculations and data from other sources [10, 11]. Our experimental production cross section 
values have been compared with the 8th TENDL release: TENDL-2015. It provides evaluated data for 
seven types of incident particles (n, p, d, t, He-3, alpha-particle, gamma) and for all the isotopes living 
more than 1 second (~ 2800 isotopes), up to 200 MeV. Since there are some differences between 
experimental data and the results of the TALYS code using default models and the TENDL-2015 
library, we have defined a combination of models, already included in the TALYS code, which better 
describes the production cross sections, for a variety of projectiles, incident energies and target 
masses. The description of the optical, pre-equilibrium and level density models have been found to 
have a great influence on the calculated production cross section values. When proton, deuteron and 
alpha particle are used as projectile, better results are in general obtained using the optical model 
described, respectively by [12], [13] and [14]. And for these three projectiles, when a pre-equilibrium 
model based on the exciton model including numerical transition rates with optical model for collision 
probabilities [15, 16] and a model for the microscopic level density from Hilaire's combinatorial 
tables [17] is used. The results of this combination of models are plotted in Fig. 1 to 4 as TALYS 1.9 
Adj. Parametrizations of the models have not been changed. They are used as they are implemented in 
TALYS. Level density or optical model parameters haven’t been tuned. 
4 Results and discussion 
TALYS version 1.9 results have been obtained using the default models (labelled Default) and using 
the combination of models (labelled Adj.) described in the section 3. In Fig. 1 to 4, the full circles 
correspond to our experimental values, the other geometrical symbols to literature data, the full lines 
to TALYS Default and the dash lines to TALYS Adj. calculations. Four reactions, extracted from 
previous published articles, are presented. They cover proton, deuteron, alpha particle beams and a 
wide range of masses. All the experimental production cross section values are compared with the 
version 1.9 of the TALYS code released in December, 2017 [10]. 
4.1 Th-226 production from the Th-232(p,3n)Pa-230 reaction 
 
 
Fig. 1: Th-232(p,3n)Pa-230 cross section 
Th-226 is a promising radionuclide for α RIT in leukaemia treatment. Th-226, with a half-life of 31 
minutes, can be produced from the α decay of U-230, which has a half-life of 21 days, thanks to a 
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generator system U-230/Th-226. We studied the U-230 production using the Th-232(p,3n)Pa-230(β-
)U-230 reaction. Our set of data for the Th-232(p,3n)Pa-230 reaction is plotted in Fig. 1. 
There is a good agreement with our experimental data and those available in the literature. The 
TALYS code version 1.9 with default models and the TENDL-2015 library values, plotted with a 
dashed-pointed line, are not able to reproduce the production cross section amplitude even if the shape 
is in good agreement with our experimental data. The TALYS 1.9 Adj. results are in perfect 
agreement with these experimental data. As TEDL-2015 and TALYS 1.9 Default curves exhibit 
roughly the same shape and amplitude, TENDL-2015 will not be plotted on the following figures. 
4.2 Re-186g production from natural tungsten 
Re-186g, with a half-life of 3.7 days, is a β- emitter used in clinical trials for the palliation of painful 
bone metastases resulting from prostate and breast cancer. It emits a 137 keV gamma ray, suited for 
SPECT imaging. The Fig. 2 shows that our experimental production cross section values are in 
agreement with the literature. The TALYS 1.9 Default calculation is far from the cross section 
amplitude. The TALYS 1.9 Adj. values are in better agreement but still underestimate the maximum 
of the cross section by 20%. 
 
 
Fig. 2: W-nat(d,x)Re-186g cross section 
4.3 Sn-117m production from natural cadmium 
 
 
Fig. 3: Cd-nat(α,x)Sn-117m cross section 
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Sn-117m is a conversion and Auger electron emitter, with a half-life of 13.6 days, useful for the 
palliation of painful bone metastases. Moreover, imaging can be achieved with its 158 keV gamma 
line. Our experimental production cross section values are in agreement with the values of Hermanne 
et al., published in 2010 (see Fig. 3). However, the Qaim and Döhler values show a shift in energy, 
roughly 10 MeV higher, for the location of the cross section’s maximum. The points have been 
degraded rather far from the initial beam energy, which could explain the shift by energy straggling 
through the foils. 
The TALYS 1.9 Default models give the good shape but results are slightly underestimated and 
shifted in energy (3 MeV lower). TALYS 1.9 Adj. models are in good agreement with the general 
behaviour of the experimental data. This combination allows reproducing the shape, the position of 
the maximum and the amplitude below 45 MeV. 
4.4 Tb-115 production from natural gadolinium 
Several terbium isotopes are suited for diagnosis or therapy in nuclear medicine. Tb-155 is of interest 
for SPECT imaging and/or Auger therapy. Tb-155 has a half-life of 5.32 days. It decays by electron 
capture process to Gd-155 (stable) by emitting Auger electrons (4.84 keV and 34.9 keV), conversion 
electrons (from 2 keV to 130 keV) and nine main gamma rays (from 86 keV to 367 keV). 
 
 
Fig. 4: Gd-nat(d,x)Tb-155 cross section 
Our experimental production cross section values are plotted in Fig. 4. They are in agreement 
with the literature data set. The TALYS 1.9 Default models give the good shape but results are 
slightly underestimated. TALYS 1.9 Adj. models are in good agreement with the general behaviour of 
the experimental data but slightly overestimated the experimental results. 
5 Conclusions 
A large set of production cross section of medical radionuclides have been collected using the 
stacked-foil technique with proton, deuteron and alpha beams delivered by the ARRONAX cyclotron 
and for various materials on a wide range of masses. Some comparisons have been systematically 
performed with the TALYS code, version 1.9. This code has been chosen because it includes a large 
number of theoretical models, the possibility to combine these models to better describe the 
experimental data and because the authors’ team is very reactive and helpful. Three main mechanisms 
have been investigated, which have a great impact on the studied observables in our work. They are 
the optical potential, the level density description and the pre-equilibrium model. A set of models have 
been found allowing a good description of all our collected data, which is different from the suggested 
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default combination of models. They can be used to get high quality data when no data are available 
in databases. 
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